Clinical Trial Update: Higher vs. Lower Doses of Dexamethasone for COVID-19 and Severe Hypoxia [Phase 3]

View source ↗

Summary

Phase 3 trial comparing higher versus lower doses of dexamethasone in COVID-19 patients with severe hypoxia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypoxia

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)

Snippet

Sponsor: Scandinavian Critical Care Trials Group | Conditions: Covid19, Hypoxia | Phase 3 | Status: COMPLETED